CVR 33575505Private limited company (ApS)Engroshandel med andre maskiner og andet udstyr (466400)VedbækFounded 16 Mar 2011
Employees
2
CVR registry, Aug 2026
-2 (-50%) over 12 months
Result
+6.2M
DKK, annual report 2025
Equity
11.2M
DKK, annual report 2025
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about Biopsafe ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexMedCap AB (publ)100% of capital and votes, since 26 Jun 2026
Lennart Bønnelykkesince 19 Oct 2026
100% of capital and votessince 26 Jun 2026
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
CVR 28840616100% of capital and votes1 Jan 2022 to 26 Jun 2026
CVR 29443963100% of capital and votes16 Mar 2011 to 1 Jan 2022
CVR records founders at incorporation. It does not record whether they are alive or still involved.
26 Jun 2026 to 2 Nov 2026.
16 Mar 2011 to 2 Nov 2026.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Gross profit | 7,541 | 6,081 | Not reported | 11,278 | Not reported |
| Operating profit | +582 | +2,658 | +919 | +6,105 | +8,643 |
| Result for the year | +250 | +1,447 | +79 | +4,087 | +6,231 |
| Equity | 4,250 | 5,698 | 5,079 | 9,087 | 11,231 |
| Total assets | 24,323 | 26,671 | 22,748 | 26,404 | 23,929 |
| Employees (average) | 3 | 2 | 4 | 3 | 4 |
| Credit metrics (Dandex calculations) | |||||
| Gross profit growth (vækst i bruttofortjeneste) | 44.8% | 32.1% | Not reportednote 1 | 55.9% | Not reportednote 1 |
| EBITDA | 3,443note 2 | 4,685 | 3,325 | 8,008 | 10,555 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) | 45.7%note 2 | 77% | Not reportednote 1 | 71% | Not reportednote 1 |
| Employee growth (vækst i antal ansatte) | 0% | -33.3% | 100% | -25% | 33.3% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | -3,622 | 15,205 | 12,389 | 8,136 | 2,502 |
| Gearing, NIBD / EBITDA | Net cashnote 2 | 3.2x | 3.7x | 1x | 0.2x |
| ROIC (afkast af investeret kapital) | 15.8% | 18.9% | 2.9% | 26.8% | 42.6% |
| Capex (investeringer i anlægsaktiver) | 0note 3 | 0note 4 | 210note 4 | 2,044note 4 | 0note 4 |
| NIBD incl. group and owner balances (NIBD inkl. koncern- og ejermellemværender) | 11,805 | 11,266 | 11,551 | 4,537 | 2,056 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may. No cash flow statement filed (class A and B are exempt).
Annual report 2025
1 Jan 2025 to 31 Dec 2025, published 24 Mar 2026
Annual report 2024
1 Jan 2024 to 31 Dec 2024, published 27 Mar 2025
Annual report 2023
1 Jan 2023 to 31 Dec 2023, published 8 Mar 2024
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 31 Mar 2023
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 14 Jun 2022
Biopsafe ApS has new leadership, a good time to reach out.
Signal, a Dandex estimate. Lapses 27 Jan 2027.
1 registered in CVR.
P-number 1016725494Bygstubben 4, 2950 Vedbæk
No other current company drawn.
No other current company drawn.
